Encompass Health CFO receives restricted stock awards

Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported stock awards in Encompass Health Common Stock.

Rhea-AI Filing Summary

Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported stock awards in Encompass Health Common Stock. On February 18, 2026, he acquired 37,588 shares as an annual restricted stock award pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. On February 19, 2026, he acquired an additional 4,430 restricted shares upon satisfaction of performance criteria from a performance share unit award granted on February 23, 2023. After these grants, his directly held stake increased to 102,353 shares, and the filing also notes indirect holdings through irrevocable trusts and his spouse.

Insider Trade Summary

Grant/Award: 42,018 shares

Grant/Award 5 txns

Insider COLTHARP DOUGLAS E

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	4,430	$0.00	$0.00
Grant/Award	Encompass Health Common Stock	37,588	$0.00	$0.00
holding	Encompass Health Common Stock	--	--	--
holding	Encompass Health Common Stock	--	--	--
holding	Encompass Health Common Stock	--	--	--

Holdings After Transaction: Encompass Health Common Stock — 102,353 shares (Direct); Encompass Health Common Stock — 27,480 shares (Indirect, By irrevocable trust); Encompass Health Common Stock — 125,631 shares (Indirect, By irrevocable trust for the benefit of children); Encompass Health Common Stock — 37,749 shares (Indirect, By spouse)

Footnotes (2)

1. F1. This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
2. F2. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Encompass Health (EHC) report for Douglas E. Coltharp?

Douglas E. Coltharp reported acquiring two restricted stock awards in Encompass Health Common Stock. He received 37,588 shares on February 18, 2026 and 4,430 shares on February 19, 2026, all as equity compensation rather than open-market purchases.

How many Encompass Health (EHC) shares does Douglas E. Coltharp hold directly after these awards?

Following the reported equity awards, Douglas E. Coltharp directly holds 102,353 shares of Encompass Health Common Stock. This figure reflects his direct ownership after the February 18 and February 19, 2026 restricted stock issuances disclosed in the Form 4 filing.

What was the purpose of the 37,588-share award to Encompass Health (EHC) CFO Coltharp?

The 37,588-share award represents an annual grant of restricted stock to Douglas E. Coltharp. It was issued pursuant to Encompass Health’s 2025 Omnibus Performance Incentive Plan, reflecting routine executive equity compensation rather than a discretionary market purchase of stock.

Why did Encompass Health (EHC) issue 4,430 restricted shares to Douglas E. Coltharp?

The 4,430 restricted shares were issued because performance criteria were satisfied under a performance share unit award. That performance share unit award was originally granted to Douglas E. Coltharp on February 23, 2023 and converted into restricted stock upon meeting the defined performance goals.

Are Douglas E. Coltharp’s Encompass Health (EHC) awards reported as purchases or grants?

The transactions are reported as grants or awards, not open-market purchases. The Form 4 uses transaction code “A” for grant, award, or other acquisition, and the price per share is shown as 0.0000, confirming these are compensation-related stock issuances.

Does the Encompass Health (EHC) Form 4 show any indirect holdings for Douglas E. Coltharp?

Yes. The filing lists indirect ownership of Encompass Health Common Stock through an irrevocable trust, an irrevocable trust for the benefit of children, and his spouse. These entries describe additional share balances held via related parties rather than direct personal holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 03:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLTHARP DOUGLAS E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/18/2026		A		37,588(1)	A	$0	97,923	D
Encompass Health Common Stock	02/19/2026		A		4,430(2)	A	$0	102,353	D
Encompass Health Common Stock								27,480	I	By irrevocable trust
Encompass Health Common Stock								125,631	I	By irrevocable trust for the benefit of children
Encompass Health Common Stock								37,749	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.

2. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.